| Name | ethyl 4-oxo-1H-1,7-naphthyridine-3-carboxylate |
|---|---|
| Synonyms |
1,5-Naphthyridine-3-carboxylic acid, 4-hydroxy-, ethyl ester
1,4-Dihydro-4-oxo-1,7-naphthyridine-3-carboxylic acid ethyl ester Ethyl 4-Hydroxy-1,5-naphthyridine-3-carboxylate |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 345.7±37.0 °C at 760 mmHg |
| Molecular Formula | C11H10N2O3 |
| Molecular Weight | 218.209 |
| Flash Point | 162.8±26.5 °C |
| Exact Mass | 218.069138 |
| PSA | 72.05000 |
| LogP | 2.87 |
| Vapour Pressure | 0.0±0.8 mmHg at 25°C |
| Index of Refraction | 1.639 |
|
~%
862546-07-4 |
| Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: WO2009/36412 A1, 2009 ; Location in patent: Page/Page column 64-65 ; WO 2009/036412 A1 |
| Precursor 1 | |
|---|---|
| DownStream 1 | |